January 2, 2020 Paul R. Gudonis President and Chief Executive Officer Myomo, Inc. One Broadway, 14th Floor Cambridge, MA 02142 Re: Myomo, Inc. Preliminary Proxy Statement on Schedule 14A Filed December 23, 2019 File No. 001-38109 Dear Mr. Gudonis: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: James H. Xu - Goodwin Procter LLP